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Renal Transplant Thrombosis in Children
By A.F. van Lieburg, M.C.J.W. de Jong, A.J. Hoitsma, F.G.M. Buskens, C.H. Schroder, and L.A.H. Monnens
Nijmegen, The Netherlands
•  Data concerning 100 consecutive renal transplantations 
in children were analyzed to determine factors enhancing the 
risk of renal transplant thrombosis. The incidence of renal 
transplant thrombosis was high, at 12%. It is concluded that 
in addition to young age and low body weight of recipient 
and young age of the donor, also a high preoperative urine 
production contributes to the occurrence of thrombosis. 
Children with hypoplastic or dysplastic kidneys are at greater 
risk for thrombosis. Considering the influence of high urine 
production of the native kidneys, it may be possible to 
prevent thrombosis by albumin and ample fluid administra­
tion.
Copyright © 1995 by W.B. Saunders Company
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HROMBOSIS of the transplanted kidney is an 
important cause of early graft failure in chil­
dren. A multicenter review concerning 1,045 renal 
transplants in children found that 22.5% of all graft 
failures occurring in the first 60 days after transplan­
tation were caused by thrombosis.1 A variety of risk 
factors has been described (Table 1), including some 
that can account for the fact that this complication 
has become mainly a pediatric problem.1*20 The influ­
ence of young age of recipient and donor has been 
emphasized especially. Another condition that has
been associated with renal transplant thrombosis in
i '
children is high urine production of the native kid­
neys, causing intravascular volume depletion.1,2 Until 
now this factor has received relatively little attention. 
Because management of thrombosis depends on pre­
vention, all predisposing factors need to be regarded. 
The goal of this study is to evaluate risk factors for 
thrombosis in a group of 100 pediatric transplanta­
tions.
MATERIALS AND METHODS
Data concerning 100 renal transplantations in children, per­
formed between 1977 and 1990 in the St Radboud University 
Hospital in Nijmegen, were collected retrospectively.
A standard surgical technique was used. All grafts were placed 
retroperitoneally in the contralateral iliac fossa. The graft vessels 
were anastomosed, using a running suture, with arteria and vena 
iliaca communis or arteria and vena iliaca externa of the recipient, 
depending on the size and length of the vessels and length of the 
ureter. Until 1983 immunosuppression was achieved with predni­
sone and azathioprine. Since then, instead of azathioprine, cyclo- 
sporine has been used, Initial doses of cyclospprine consisted of 3 
or 5 mg/kg per 24 hours intravenously, followed by 15 or 18 mg/kg 
per 24 hours orally after 48 hours. Perioperative fluid management: 
during surgery 2.5 L saline-glucose solution was given per 1.73 m2 
body surface area. In addition, since 1983, man ni toi solution 20%
was administered in a dosage of 250 mL per 1.73 m2 body surface 
area, and since 1989 children weighing less than 18 kg received 20 
mL albumin solution 10% per hour during the first 2 hours of the 
operation. Blood pressure was kept at a level considered appropri­
ate for the particular child. Postoperatively, saline-glucose solution 
was given in an amount of 1 L  per 1.73 m2 body surface area plus 
diuresis every 24 hours.
Thrombosis was diagnosed on clinical (cessation of urine produc­
tion, signs of thrombosis in the homolateral lower extremity) and 
radiological (radionuclide scan, arteriography) findings and subse­
quently confirmed at surgical exploration and histological examina­
tion.
Factors that, according to the literature, predispose to transplant 
thrombosis were analyzed (Table 1). For statistical calculations, 
the Wiicoxon test, x2 test, and Pearson correlation test were used 
where appropriate. Significance was accepted for a P value of less 
than .05.
RESULTS
Eighty-one children received 93 postm ortem  donor 
transplants (PM D) and 7 living related donor trans­
plants (LRD). Eighty-one underw ent the procedure 
for the first, 16 for the second, and 3 for the third 
time. All patients except 1 had been on hemodialysis 
or peritoneal dialysis with a mean duration of 18.6 
months (SD 14.1).
In 12 recipients, thrombosis of the allograft with 
subsequent graft loss occurred. In 4 patients, the 
obstruction was located in the renal artery, and in 7 
patients in the renal vein. In 1 patient the site of 
thrombosis was uncertain because of late transplan- 
tectomy of a necrotic kidney. This was the only 
patient in which on histological examination rejection 
could not be excluded.
The children with throm bosis w ere younger 
(P < .04, Table 2) and of a lower mean body weight 
(P < .03, Table 2) than the other children. Com pared 
with the group without thrombosis, mean p reopera­
tive urine production was twice as high in the throm ­
bosis group (P = .0100, Table 2, Fig 1). Children with 
a relatively high diuresis (> 3 6  m L/kg) and throm bo­
sis did not differ from children having the same 
diuresis but no thrombosis regarding their weight and 
age of their donor. There was no correlation between 
age or weight of the recipient and diuresis per
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Table 1. Etiological Factors in Renal Transplant Thrombosis
Young recipients (and low body weight)
High urine production of the native kidneys
Prior native nephrectomy
Primary renal disease
Rejection
Young donors
Status of the donor (PMD or LRD)
Multiple donor vessels 
Long cold storage time 
Surgical technique 
Peroperative hypotension 
Cyclosporine immunosuppression 
History of multiple fistula thromboses 
Renal graft artery stenosis 
Use of erythropoietin
Data from references 1 through 20.
number of transplants
10 20 30 40 50 60 70
diuresis in ml/kg per 24  hr
kilogram. The num ber of pretransplant nephrecto­
mies was not significantly different.
With respect to the primary disease, a relatively 
high incidence of thrombosis was seen in children 
with a renal hypoplasia or dysplasia (P <  .002, Table
2, Fig 2). Compared with children with other diseases, 
age of recipient and donor were not significantly 
lower in this group.
In the thrombosis group, 2 children received a 
kidney from a parent. Because in both patients 
anatomical variations of donor an d /o r recipient ves­
sels could have attributed to the individual risk of 
thrombosis, their medical histories are described in 
detail in the following section.
Table 2. Clinical Characteristics and Surgical Parameters 
in Transplantations With and Without Thrombosis
Thrombosis No Thrombosis P Value
Number of transplants 12 88
Bilateral nephrectomy in the
past (%) 16.7 12.5 NS
Renal hypoplasia/dysplasia
(%) 50.0 10.2 <.002
Age of recipient (yr) 7.9 ± 4.0 10.6 ±  3.9 <.040
Body weight of recipient (kg) 21.3 ±  3.1 29.8 ±  12.3 <.030
Preoperative diuresis (mL/
kg/24 h)* 40.0 ± 23.8 20.2 ±  20.2 .010
Age of PMD (yr)T 7.2 ± 8.1 18.1 ±  15.1 <.020
Cold storage time (h) 23.5 ± 12.3 28.6 ±  10.0 NS
Anastomosis construction
time {min) 39.1 ± 5.3 36.6 ±  9.6 NS
Multiple arteries (%) 16.7 3.4 NS
Multiple veins (%) 8.3 6.8 NS
Treatment with mannitol (%) 66.7 75.0 NS
Treatment with cyclosporine
(%) 66.7 60.2 NS
Treatment with erythropoi­
etin (%) 8.3 8.0 NS
*Number of transplants, 12 in thrombosis and 87 in nonthrombosis 
group.
tNumber of transplants, 10 in thrombosis and 83 in nonthrombosis 
group.
Fig 1. Preoperative diuresis (n = 99 because of lack of quantitative 
data of 1 incontinent child).
Patient No. 67
The primary disease of patient no. 67 was renal 
hypoplasia. Hemodialysis was started at the age of 7 
years. W hen he was 11 years old, he received a kidney 
from his father (age 41). Preoperative diuresis was 36 
m L/kg per 24 hours. Immunosuppression was 
achieved with cyclosporine and prednisone. Intrave­
nous fluid and mannitol were administered as de­
scribed above. Preoperative angiography of the donor 
kidney had shown the existence of a'sm all artery 
supplying the inferior segment of the kidney. This 
artery was anastomosed end-to-side to the main 
donor artery. The renal vein was anastomosed to the 
left vena iliaca externa, that ended in a venous 
convolute. An extra problem was the minimal length 
of the donor vein, which made it necessary to implant 
the kidney upside down. The reconstructed arteria 
renalis was anastomosed with the arteria iliaca ex­
terna. After release of circulation the color of the
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kidney was adequate and some drops of urine were 
produced. However, nearly no urine was produced 
postoperatively. A radionuclide scan was made the 
same day, which showed no perfusion. At laparatomy 
it was found that both the renal artery and vein 
contained a thrombus, and a transplantectomy was 
performed. Histological examination showed no signs 
of rejection and was compatible with arterial obstruc­
tion.
Patient No. 100
Patient no. 100 was known since birth to have 
urethral valves and renal failure of moderate severity. 
At the age of 3 years, continuous ambulatory perito­
neal dialysis (CAPD) was started. Because of severe 
hypertension both kidneys had been removed. W hen 
he was 5 years old he received a kidney from his 
mother (age 32). Immunosuppression was achieved 
with cyclosporine and prednisone. In addition to the 
standard fluid management described above, he re­
ceived albumin because his weight was less than 18 kg 
and he was the first patient who received low molecu­
lar weight heparine (2 dosages of 50 U/kg per 24 
hours).
The donor kidney had two veins of different caliber 
at one patch. The largest vein was anastomosed 
end-to-side to the vena iliaca communis, the little one 
was ligated because it was not possible to anastomose 
it to the main vein. The renal artery was anastomosed 
to the arteria iliaca communis. After release of 
circulation the color of the kidney was not immedi­
ately adequate and it took about 10 minutes before 
the first drops of urine were produced. Postopera­
tively there was nearly no urine production. The same 
day peritoneal dialysis was necessary because of a 
high serum potassium level. The next morning a 
radionuclide scan showed multiple defects, Relapa­
rotomy was performed, and some thrombi were 
removed from the renal vein. However, this proce­
dure did not result in production of urine. The next 
day a second scan was made that showed no perfu­
sion, and the transplant was removed. Histological 
examination showed an obstructing thrombus of the 
renal vein that seemed to have existed for several 
days. No signs of rejection were found.
The other 10 children who suffered from thrombo­
sis were grafted with a PMD kidney. Their donors 
were of a lower mean age than the PMDs in the 
nonthrombosis group (P < .02, Table 2). One of 
these patients received a kidney with two arteries (no 
vascular reconstruction). In the total thrombosis 
group, a predisposition for the occurrence of throm­
bosis in the presence of multiple arteries or veins 
could not be shown (Table 2). The time necessary for
construction of the anastomosis did not differ signifi­
cantly from that of the nonthrom bosis group, nor did 
the cold storage time. In one patient diffuse bleeding 
in the transplant kidney region was detected 1 day 
before diagnosis of thrombosis. This was the only 
patient in which hypotension occurred shortly before 
developing thrombosis. Over the years there has been 
no essential change in surgical technique or team  
(two different surgeons were involved), nor was there 
a clustering of the cases of thrombosis in time. No 
relation to the use of cyclosporine or its dosage could 
be detected (Table 2). Thrombosis did not occur in 
the children with a known renal artery stenosis of the 
graft (8%). Of the children who suffered from throm ­
bosis, only one had been treated  with erythropoietin 
before transplantation (Table 2). Two others had a 
history of multiple arteriovenous fistula thromboses. 
No one was known to have a coagulation disorder,
All thromboses resulted in transplantectomy, mostly 
within 6 days postoperatively. Only one attem pt at 
thrombectomy was made (see patient no. 100) that 
failed. All patients who suffered from thrombosis are 
alive 1 to 10 years after transplantation, 7 of them 
after a successful retransplantation.
DISCUSSION
Renal transplant thrombosis was reported  by H ar­
mon et a l1 with an incidence of 2.6% in 1,045 
transplantations in children. R ecent figures of this 
m ulticenter study after performing 1,667 transplanta­
tions show an incidence of 3.4%.2 LRD recipients 
younger than 6 years and PM D recipients who re ­
ceived grafts from young donors, especially with a 
long cold storage time, were found to be at increased 
risk for thrombosis. Furtherm ore the risk in LRD  
recipients in the youngest age group turned out to be 
significantly larger if no prior dialysis had taken place. 
Harmon et al suggested that these children were 
likely to have a high urine production of the native 
kidneys and that this could be responsible for the 
increased risk of thrombosis in the LRD group. They 
assumed that high diuresis might induce intravascular 
volume depletion more readily and result in a re ­
duced perfusion of the (larger) donor kidney.1 W hen 
this is true one would expect that pretransplant 
nephrectomy might lower the risk of throm bosis.3 
However, Harmon et al could not confirm this. 
Recently, Sheldon et al5 put even m ore emphasis on 
the influence of low flow states, but did not base this 
influence on facts. The present study quantifies the 
relation between high urine output of the native 
kidneys and thrombosis. No difference in the num ber 
of pretransplant nephrectom ies was found, but this 
could be because this operation is not perform ed very
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often in our center. The observation that children 
with renal hypbplasia or dysplasia, who are generally 
polyuric, developed thrombosis m ore often, draws the 
attention toward the influence of the primary renal 
disease. Harmon et al1 did not detect this relation­
ship, possibly because of the grouping of hypoplasia 
in one category with aplasia. The predisposition for 
thrombosis was less obvious in children with urethral 
valves, who generally have dysplastic kidneys too, but 
the relatively high incidence (2 out of 11 children)
s
cannot be neglected.
The most accepted causal mechanism regarding 
low donor and recipient age seems to be the size of 
structures. Especially size discrepancy results in tech­
nical problems,4 however, in our thrombosis group all 
PMDs were children. The presence of multiple ves­
sels makes the procedure more complicated as well, 
although in this study no relation with the occurrence 
of thrombosis was found (Table 2). Nevertheless, the 
relatively high incidence of thrombosis in patients 
that received a kidney from a LRD  could be caused 
by the presence of variations of vascular anatomy in 
the two LRD recipients with this complication.
No thrombogenic effect could be ascribed to cyclo- 
sporine, although the absence of a decreasing ten­
dency with time regarding the num ber of thromboses, 
in spite of an increase of experience, gives food for 
thought. Several reports on this effect of cyclosporine 
have been published.12'19 A  defective release of plas­
minogen activator and high plasma levels of plasmino­
gen activator inhibitor have been found in patients on 
cyclosporine.18 O ther studies suggest that this could 
be mediated by a prostacycline deficiency.19
The small num ber of patients (n = 8) treated with 
erythropoietin does not allow us to exclude the 
possibility that this treatm ent increases the risk of 
thrombosis, although no significant difference was 
found (Table 2).
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The observation that in the present study 80% of 
graft failures in the first 60 days after transplantation 
were caused by thrombosis once more emphasizes the 
importance of prevention of this problem. Because 
high urine production turned out to be a risk factor in 
our center, we reconsidered our fluid management. 
In our opinion the amount of saline/glucose and 
mannitol solution administered is sufficient to correct 
for insensible water loss and third spacing. In the 
past, when dialysis was necessary just before transplan­
tation, our goal was to achieve normal dry body 
weight. However, since 1989, we leave some overhy­
dration. Davidson et al21 stated that high-dose albu­
min infusion (1.2 to 1.6 g/kg) is associated with a 
significant decrease of nonfunction rates. Further­
more favorable results of prophylactic administration 
of low molecular weight heparin in patients with a 
predisposition for thrombosis have been reported.11 
These findings made us decide to change our policy; 
we introduced albumin in higher dosages (1 g per 
kilogram of body weight) during operation in all 
patients. Moreover, we now administer low molecular 
weight heparin if recipients weigh less than 20 kg or if 
donors are younger than 6 years.
It is concluded that, in addition to young age of the 
recipient and donor and low weight of the recipient, 
high preoperative diuresis deserves attention when 
assessing the individual risk for thrombosis. In a 
prospective study we will evaluate the effect of 
addition of heparin and larger amounts of albumin to 
our perioperative regime.
ADDENDUM
After the series of 100 transplantations described 
above, 40 additional pediatric transplantations were 
performed in our hospital, two of which were compli­
cated by thrombosis (4.8%).
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